Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

doi:10.2807/1560-7917.ES.2020.25.45.2001886

. 2020 Nov;25(45):2001886.

doi: 10.2807/1560-7917.ES.2020.25.45.2001886.

Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

Dominique L Monnet¹, Stephan Harbarth²

Affiliations

¹ European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
² Infection Control Program and Division of Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

PMID: 33183403
PMCID: PMC7667630
DOI: 10.2807/1560-7917.ES.2020.25.45.2001886

Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

Dominique L Monnet et al. Euro Surveill. 2020 Nov.

. 2020 Nov;25(45):2001886.

doi: 10.2807/1560-7917.ES.2020.25.45.2001886.

Authors

Dominique L Monnet¹, Stephan Harbarth²

Affiliations

¹ European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
² Infection Control Program and Division of Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

PMID: 33183403
PMCID: PMC7667630
DOI: 10.2807/1560-7917.ES.2020.25.45.2001886

No abstract available

Keywords: COVID-19; antibiotic use; antimicrobial resistance; automated surveillance; bacterial infections; hygiene; infection control; respiratory viruses; surveillance; viral infections.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Cited by

No Changes in the Occurrence of Methicillin-Resistant Staphylococcus aureus (MRSA) in South-East Austria during the COVID-19 Pandemic.
Zarfel G, Schmidt J, Luxner J, Grisold AJ. Zarfel G, et al. Pathogens. 2023 Nov 2;12(11):1308. doi: 10.3390/pathogens12111308. Pathogens. 2023. PMID: 38003773 Free PMC article.
Impact of the COVID-19 Pandemic on Community Antibiotic Prescribing and Stewardship: A Qualitative Interview Study with General Practitioners in England.
Borek AJ, Maitland K, McLeod M, Campbell A, Hayhoe B, Butler CC, Morrell L, Roope LSJ, Holmes A, Walker AS, Tonkin-Crine S, On Behalf Of The Step-Up Study Team. Borek AJ, et al. Antibiotics (Basel). 2021 Dec 14;10(12):1531. doi: 10.3390/antibiotics10121531. Antibiotics (Basel). 2021. PMID: 34943743 Free PMC article.
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic.
Catalano A, Iacopetta D, Ceramella J, Pellegrino M, Giuzio F, Marra M, Rosano C, Saturnino C, Sinicropi MS, Aquaro S. Catalano A, et al. Viruses. 2023 Aug 30;15(9):1843. doi: 10.3390/v15091843. Viruses. 2023. PMID: 37766250 Free PMC article. Review.
Infection with the multidrug-resistant Klebsiella pneumoniae New Delhi metallo-B-lactamase strain in patients with COVID-19: Nec Hercules contra plures?.
Janc J, Słabisz N, Woźniak A, Łysenko L, Chabowski M, Leśnik P. Janc J, et al. Front Cell Infect Microbiol. 2024 Apr 16;14:1297312. doi: 10.3389/fcimb.2024.1297312. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38690325 Free PMC article.
Antimicrobial prescribing in a secondary care setting during the COVID-19 pandemic.
Tadros MM, Boshra MS, Scott M, Fleming G, Magee F, Hamed MI, Abuelhana A, Courtenay A, Salem HF, Burnett K. Tadros MM, et al. JAC Antimicrob Resist. 2023 Nov 13;5(6):dlad117. doi: 10.1093/jacamr/dlad117. eCollection 2023 Dec. JAC Antimicrob Resist. 2023. PMID: 37965099 Free PMC article.

See all "Cited by" articles

References

1. European Centre for Disease Prevention and Control (ECDC). COVID-19 situation update for the EU/EEA and the UK, as of 12 Nov 2020. Stockholm: ECDC. [Accessed: 12 Nov 2020]. Available from: https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea
1. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66. 10.1016/S1473-3099(18)30605-4 - DOI - PMC - PubMed
1. Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7):e12560. 10.15252/emmm.202012560 - DOI - PMC - PubMed
1. Cantón R, Gijón D, Ruiz-Garbajosa P. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic. Curr Opin Crit Care. 2020;26(5):433-41. 10.1097/MCC.0000000000000755 - DOI - PubMed
1. Donà D, Di Chiara C, Sharland M. Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact. J Hosp Infect. 2020;106(1):198-9. 10.1016/j.jhin.2020.05.020 - DOI - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information

[1] European Centre for Disease Prevention and Control (ECDC). COVID-19 situation update for the EU/EEA and the UK, as of 12 Nov 2020. Stockholm: ECDC. [Accessed: 12 Nov 2020]. Available from: https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea

[2] European Centre for Disease Prevention and Control (ECDC). COVID-19 situation update for the EU/EEA and the UK, as of 12 Nov 2020. Stockholm: ECDC. [Accessed: 12 Nov 2020]. Available from: https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea

[3] Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66. 10.1016/S1473-3099(18)30605-4 - DOI - PMC - PubMed

[4] Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66. 10.1016/S1473-3099(18)30605-4 - DOI - PMC - PubMed

[5] Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7):e12560. 10.15252/emmm.202012560 - DOI - PMC - PubMed

[6] Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7):e12560. 10.15252/emmm.202012560 - DOI - PMC - PubMed

[7] Cantón R, Gijón D, Ruiz-Garbajosa P. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic. Curr Opin Crit Care. 2020;26(5):433-41. 10.1097/MCC.0000000000000755 - DOI - PubMed

[8] Cantón R, Gijón D, Ruiz-Garbajosa P. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic. Curr Opin Crit Care. 2020;26(5):433-41. 10.1097/MCC.0000000000000755 - DOI - PubMed

[9] Donà D, Di Chiara C, Sharland M. Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact. J Hosp Infect. 2020;106(1):198-9. 10.1016/j.jhin.2020.05.020 - DOI - PMC - PubMed

[10] Donà D, Di Chiara C, Sharland M. Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact. J Hosp Infect. 2020;106(1):198-9. 10.1016/j.jhin.2020.05.020 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

Affiliations

Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical